| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.58 | 0.001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |